NKF Trade Mark NKF Helpline (0845) 601 02 09 NKF Campaigns Zone:
Government & Parliament

High-visibility version


NKF Campaigns

Parl Questions

Answers to Parliamentary Questions

Questions Asked - 5 February 2003 Ref: PQ 02797, PQ02798, PQ02804, PQ02805
Written Answer - 12 February 2003 2002/2003

NSF ON RENAL SERVICES

Mr Peter Pike (Lab. Burnley):

269 To ask the Secretary of State for Health, whether he plans to include in the National Service Framework on Renal Services (a) patient care pathways, from dialysis to transplantation, (b) long-term follow up clinics and (c) screening of key indicators, to include blood pressure and blood lipids; and if he will make a statement. (96199)

270 To ask the Secretary of State for Health, if he plans to include guidelines to ensure patient access to transplantation services for the National Service Framework on Renal Services; and if he will make a statement. (96132)

275 To ask the Secretary of State for Health, when the National Service Framework on Renal Services will be published; whether resources will be committed to ensure its implementation; and if he will make a statement. (96133)

273 To ask the Secretary of State for Health, what plans he has to include standards for increasing organ donor numbers in the renal National Service Framework; whether this will include raising awareness of options including living related Donors; and if he will make a statement. (96198)

MR LAMMY:

The renal national service framework (NSF) will be published in due course. It will set national standards and provide a national direction for renal services that will need to be achieved over ten years. There will be flexibility at local level to plan to meet local priorities and to use local innovation within the framework of the national standards.

The issues of increasing and raising awareness of organ donation and access to transplantation services are within the scope of the renal NSF and will be considered fully during the NSF development process. Consideration will also be given to the patient care pathway and to the prevention and treatment of chronic kidney disease.